AlpENa Biosciences Overview
- Year Founded
-
2023
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
3
AlpENa Biosciences General Information
Description
Developer of bispecific antibodies designed to activate immune cells to target and destroy tumor cells as cancer therapeutics. The company is currently operating in Stealth Mode.
Contact Information
Corporate Office
- Aeschenvorstadt 36
- 4051 Basel
- Switzerland
Corporate Office
- Aeschenvorstadt 36
- 4051 Basel
- Switzerland
AlpENa Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Dec-2024 | Completed | Stealth |
AlpENa Biosciences Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amsterdam Academic Ventures | Venture Capital | Minority | ||
| Amsterdam UMC Ventures Holding | Venture Capital | Minority | ||
| Versant Ventures | Venture Capital | Minority |
AlpENa Biosciences FAQs
-
When was AlpENa Biosciences founded?
AlpENa Biosciences was founded in 2023.
-
Where is AlpENa Biosciences headquartered?
AlpENa Biosciences is headquartered in Basel, Switzerland.
-
What industry is AlpENa Biosciences in?
AlpENa Biosciences’s primary industry is Biotechnology.
-
Is AlpENa Biosciences a private or public company?
AlpENa Biosciences is a Private company.
-
What is AlpENa Biosciences’s current revenue?
The current revenue for AlpENa Biosciences is .
-
Who are AlpENa Biosciences’s investors?
Amsterdam Academic Ventures, Amsterdam UMC Ventures Holding, and Versant Ventures have invested in AlpENa Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process